Olanzapine vs haloperidol in geriatric s
β
J. S. Kennedy; D. Jeste; C. J. Kaiser; S. Golshan; G. A. Maguire; G. Tollefson;
π
Article
π
2003
π
John Wiley and Sons
π
English
β 121 KB
## Abstract ## Objectives To compare the sixβweek clinical response and safety profile of schizophrenia patients, age β₯60 years, receiving olanzapine (OLZ) __vs__ haloperidol (HAL) in a double blind, randomized trial. ## Methods Doubleβblind data on patients age β₯60 randomized to 5βmg/d OLZ (__n